113 related articles for article (PubMed ID: 35508175)
1. ISL2 is a putative tumor suppressor whose epigenetic silencing reprograms the metabolism of pancreatic cancer.
Ozturk H; Cingoz H; Tufan T; Yang J; Adair SJ; Tummala KS; Kuscu C; Kinali M; Comertpay G; Nagdas S; Goudreau BJ; Luleyap HU; Bingul Y; Ware TB; Hwang WL; Hsu KL; Kashatus DF; Ting DT; Chandel NS; Bardeesy N; Bauer TW; Adli M
Dev Cell; 2022 Jun; 57(11):1331-1346.e9. PubMed ID: 35508175
[TBL] [Abstract][Full Text] [Related]
2. ISL2 modulates angiogenesis through transcriptional regulation of ANGPT2 to promote cell proliferation and malignant transformation in oligodendroglioma.
Qi L; Wang ZY; Shao XR; Li M; Chen SN; Liu XQ; Yan S; Zhang B; Zhang XD; Li X; Zhao W; Pan JA; Zhao B; Zhang XD
Oncogene; 2020 Sep; 39(37):5964-5978. PubMed ID: 32753650
[TBL] [Abstract][Full Text] [Related]
3. The U2AF2 /circRNA ARF1/miR-342-3p/ISL2 feedback loop regulates angiogenesis in glioma stem cells.
Jiang Y; Zhou J; Zhao J; Zhang H; Li L; Li H; Chen L; Hu J; Zheng W; Jing Z
J Exp Clin Cancer Res; 2020 Sep; 39(1):182. PubMed ID: 32894165
[TBL] [Abstract][Full Text] [Related]
4. Methylation-mediated silencing of the LIM homeobox 6 (LHX6) gene promotes cell proliferation in human pancreatic cancer.
Abudurexiti Y; Gu Z; Chakma K; Hata T; Motoi F; Unno M; Horii A; Fukushige S
Biochem Biophys Res Commun; 2020 Jun; 526(3):626-632. PubMed ID: 32248980
[TBL] [Abstract][Full Text] [Related]
5. Metabolic plasticity in heterogeneous pancreatic ductal adenocarcinoma.
Liang C; Qin Y; Zhang B; Ji S; Shi S; Xu W; Liu J; Xiang J; Liang D; Hu Q; Ni Q; Xu J; Yu X
Biochim Biophys Acta; 2016 Dec; 1866(2):177-188. PubMed ID: 27600832
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic and Transcriptional Control of the Epidermal Growth Factor Receptor Regulates the Tumor Immune Microenvironment in Pancreatic Cancer.
Li J; Yuan S; Norgard RJ; Yan F; Sun YH; Kim IK; Merrell AJ; Sela Y; Jiang Y; Bhanu NV; Garcia BA; Vonderheide RH; Blanco A; Stanger BZ
Cancer Discov; 2021 Mar; 11(3):736-753. PubMed ID: 33158848
[TBL] [Abstract][Full Text] [Related]
7. Adaptation of pancreatic cancer cells to nutrient deprivation is reversible and requires glutamine synthetase stabilization by mTORC1.
Tsai PY; Lee MS; Jadhav U; Naqvi I; Madha S; Adler A; Mistry M; Naumenko S; Lewis CA; Hitchcock DS; Roberts FR; DelNero P; Hank T; Honselmann KC; Morales Oyarvide V; Mino-Kenudson M; Clish CB; Shivdasani RA; Kalaany NY
Proc Natl Acad Sci U S A; 2021 Mar; 118(10):. PubMed ID: 33653947
[TBL] [Abstract][Full Text] [Related]
8. LHX6 acts as a novel potential tumour suppressor with epigenetic inactivation in lung cancer.
Liu WB; Jiang X; Han F; Li YH; Chen HQ; Liu Y; Cao J; Liu JY
Cell Death Dis; 2013 Oct; 4(10):e882. PubMed ID: 24157876
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional control of autophagy-lysosome function drives pancreatic cancer metabolism.
Perera RM; Stoykova S; Nicolay BN; Ross KN; Fitamant J; Boukhali M; Lengrand J; Deshpande V; Selig MK; Ferrone CR; Settleman J; Stephanopoulos G; Dyson NJ; Zoncu R; Ramaswamy S; Haas W; Bardeesy N
Nature; 2015 Aug; 524(7565):361-5. PubMed ID: 26168401
[TBL] [Abstract][Full Text] [Related]
10. Functional Genomics Identifies Metabolic Vulnerabilities in Pancreatic Cancer.
Biancur DE; Kapner KS; Yamamoto K; Banh RS; Neggers JE; Sohn ASW; Wu W; Manguso RT; Brown A; Root DE; Aguirre AJ; Kimmelman AC
Cell Metab; 2021 Jan; 33(1):199-210.e8. PubMed ID: 33152323
[TBL] [Abstract][Full Text] [Related]
11. miR-615-5p is epigenetically inactivated and functions as a tumor suppressor in pancreatic ductal adenocarcinoma.
Gao W; Gu Y; Li Z; Cai H; Peng Q; Tu M; Kondo Y; Shinjo K; Zhu Y; Zhang J; Sekido Y; Han B; Qian Z; Miao Y
Oncogene; 2015 Mar; 34(13):1629-40. PubMed ID: 24769899
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic inactivation of IRX4 is responsible for acceleration of cell growth in human pancreatic cancer.
Chakma K; Gu Z; Abudurexiti Y; Hata T; Motoi F; Unno M; Horii A; Fukushige S
Cancer Sci; 2020 Dec; 111(12):4594-4604. PubMed ID: 32894817
[TBL] [Abstract][Full Text] [Related]
13. Roles of autophagy and metabolism in pancreatic cancer cell adaptation to environmental challenges.
Maertin S; Elperin JM; Lotshaw E; Sendler M; Speakman SD; Takakura K; Reicher BM; Mareninova OA; Grippo PJ; Mayerle J; Lerch MM; Gukovskaya AS
Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G524-G536. PubMed ID: 28705806
[TBL] [Abstract][Full Text] [Related]
14. LncRNA PWAR6 regulates proliferation and migration by epigenetically silencing YAP1 in tumorigenesis of pancreatic ductal adenocarcinoma.
Huang S; Li Y; Hu J; Li L; Liu Z; Guo H; Jiang B; Chen J; Li J; Xiang X; Deng J; Xiong J
J Cell Mol Med; 2021 May; 25(9):4275-4286. PubMed ID: 33834618
[TBL] [Abstract][Full Text] [Related]
15. A tumorigenic factor interactome connected through tumor suppressor microRNA-198 in human pancreatic cancer.
Marin-Muller C; Li D; Bharadwaj U; Li M; Chen C; Hodges SE; Fisher WE; Mo Q; Hung MC; Yao Q
Clin Cancer Res; 2013 Nov; 19(21):5901-13. PubMed ID: 23989979
[TBL] [Abstract][Full Text] [Related]
16. Interaction of transcription factors Islet2 and Nr2f1b to control vascular patterning during zebrafish development.
Wang YS; Huang YS; Chiu CC; Wu TY; Zhou JQ; Liang SR; Tai MH; Wu CY
Biochem Biophys Res Commun; 2022 May; 604():123-129. PubMed ID: 35303678
[TBL] [Abstract][Full Text] [Related]
17. DLC-1 is a candidate biomarker methylated and down-regulated in pancreatic ductal adenocarcinoma.
Xue YZ; Wu TL; Wu YM; Sheng YY; Wei ZQ; Lu YF; Yu LH; Li JP; Li ZS
Tumour Biol; 2013 Oct; 34(5):2857-61. PubMed ID: 23681804
[TBL] [Abstract][Full Text] [Related]
18. ZBED2 is an antagonist of interferon regulatory factor 1 and modifies cell identity in pancreatic cancer.
Somerville TDD; Xu Y; Wu XS; Maia-Silva D; Hur SK; de Almeida LMN; Preall JB; Koo PK; Vakoc CR
Proc Natl Acad Sci U S A; 2020 May; 117(21):11471-11482. PubMed ID: 32385160
[TBL] [Abstract][Full Text] [Related]
19. Visual Neurons in the Superior Colliculus Innervated by Islet2
Kay RB; Triplett JW
Front Neural Circuits; 2017; 11():73. PubMed ID: 29066954
[TBL] [Abstract][Full Text] [Related]
20. SERPINB5 and AKAP12 - expression and promoter methylation of metastasis suppressor genes in pancreatic ductal adenocarcinoma.
Mardin WA; Petrov KO; Enns A; Senninger N; Haier J; Mees ST
BMC Cancer; 2010 Oct; 10():549. PubMed ID: 20939879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
